Power Life Science

What Power Life Science does

Power Life Sciences, Inc. (operating as Power) is a San Francisco-based health technology company founded in 2022 by Bask Gill and Li, motivated by the founders' personal experience navigating immunotherapy access for Gill's father following a multiple myeloma diagnosis. The company operates a patient-facing web platform, withpower.com, that aggregates approximately 31,000 active clinical trials across more than 10,000 medical conditions and 50,000 cities, and connects them with a network of 100,000 researchers. The platform uses AI-supported matching — combining a recommendation engine that maps patient profiles to trial eligibility criteria with a natural-language-processing chat tool — to streamline trial discovery, with the company stating applications can be completed in roughly one minute. The platform is free for patients and is built on HIPAA- and SOC 2 Type 2-compliant AWS infrastructure with Vanta-powered continuous security monitoring, and the company also attests to GDPR and CCPA compliance.

Power pursues a hybrid go-to-market: a self-serve, product-led growth motion on the consumer side (browse, profile, apply) layered with an emerging enterprise motion targeted at clinical trial sponsors, research coordinators, and healthcare providers for paid patient recruitment services. Revenue is described as recurring from sponsor and researcher contracts, though no pricing, contract values, or named anchor customers are publicly disclosed. The company has raised approximately $19 million across two rounds — a $7 million seed in 2022 led by CRV and Footwork, and a roughly $11.93 million Regulation D offering in December 2023 led by Contrary and Kin Ventures, with participation from 14W, AirAngels, Artis Ventures, Footwork, Moment Ventures, and N49P. Beyond the core matching platform, the company has launched a consumer supplement product, High Impact Plant Protein, signaling an early brand-extension into adjacent consumer health categories.

Name

Power Life Science

Legal name

Power Life Sciences, Inc.

Website

https://withpower.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Power Life Science operates a patient-facing platform that uses AI matching and NLP chat to connect individuals with relevant clinical trials across 31,000+ studies, serving patients seeking new treatments while monetizing through sponsor and researcher recruitment services.

Ownership category

akta.pro rank

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Clinical Trial Connection Services: Platform connects patients with clinical trials run by sponsors and researchers. Revenue appears derived from facilitating patient recruitment for trial sponsors and research institutions. Terms indicate data sharing with trial connections and research partners.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Power operates a patient-facing AI-powered clinical trial matching platform (withpower.com) that aggregates more than 31,000 active trials, 100,000 researchers, 10,000 medical conditions, and 50,000 cities. Patients search by condition, location, and drug/treatment type, create health profiles, and apply to trials in a streamlined process designed to take about a minute, with AI-driven matching and a conversational chat assistant. On the supply side, the platform provides trial sponsors and researchers with patient recruitment services under subscription/recurring commercial arrangements.

Product overview

Power Life Sciences operates primarily as a clinical trial matching platform (Power), helping patients discover and connect with clinical trials across 31k+ trials, 100k+ researchers, and 10k+ medical conditions. The platform combines AI-powered recommendation and natural language processing to match patients with trials based on their health profiles. Additionally, the company has launched a consumer supplement product called High Impact Plant Protein.

Differentiator

Problem solved

Functional benefit

Products and services

• Power Clinical Trial Matching Platform Online patient-facing platform that helps individuals discover, evaluate, and apply to clinical trials using AI-powered matching. Features a database of 31k+ clinical trials, 100k+ researchers, 10k+ medical conditions, and 50k+ cities. Used by patients seeking access to investigational treatments.
• Trial Search & Browse Search and browse functionality that lets patients filter and explore clinical trials by condition, location, and drug/treatment type, with filters for trial phase, status, treatment type, and paid participation options. Available to patients on the public website.
• Patient Profile & Application Streamlined patient registration and clinical trial application system that lets users create health profiles and apply to trials in approximately one minute, enabling matching against trial eligibility criteria.
• AI-Supported Chat Tool Conversational AI assistant using natural language processing to help users navigate the platform, answer questions about clinical trials, and provide personalized assistance during the trial search and application process.
• Sponsor and Researcher Recruitment Services Enterprise service through which clinical trial sponsors and research institutions access Power's patient pipeline for trial recruitment, sold via direct sales under recurring subscription/recruitment arrangements.
• High Impact Plant Protein Consumer plant-based protein supplement formulated with HMB, vitamin D3, and digestive enzymes, targeting muscle maintenance in adults over 40. Positioned as a clean vegan option with fully disclosed ingredients and third-party testing.

Quantifiable outcome

• 31k+ active clinical trials listed on platform
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• AWS (Amazon Web Services)coreTechnology or IntegrationCloud infrastructure provider backing Power's platform. AWS provides isolated, secure, and highly available infrastructure for the company's operations.
• VantacoreTechnology or IntegrationAutomated security compliance platform used to regularly run tests scanning for infrastructure misconfigurations and vulnerabilities, supporting SOC 2 compliance.
• Clinical Research Sites and StaffcoreStrategic or Co-development PartnerClinical trial sites and investigators that patients connect with through the platform; these are the research facilities running trials listed on Power.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Antidote (Meili Health): Antidote is a direct competitor running a patient-facing clinical trial matching platform with sponsor recruitment services, very similar in GTM model and target customers to Power. Comparable on scale, AI matching approach, and monetization from pharma sponsors.
• Massive Bio: AI-driven clinical trial matching focused on oncology patients, with a deep-learning patient pre-screening engine for pharma sponsors. Comparable to Power in patient recruitment model and AI differentiation, though more concentrated in cancer indications.
• Deep 6 AI: Deep 6 AI uses AI and NLP to mine EHR data for clinical trial patient recruitment, selling into sponsors and research sites. Comparable to Power's enterprise recruitment motion, though Deep 6 operates upstream at the EHR/site level rather than the consumer patient level.
• Mendel: Mendel applies AI to clinical trial operations and patient cohort identification, with a strong focus on structuring unstructured medical data. Comparable to Power as an AI-first clinical trial enablement vendor targeting pharma sponsors.
• SubjectWell: SubjectWell recruits patients for clinical trials through a consumer-facing platform and performance-based model. Comparable to Power on the patient-recruitment business model and revenue mechanics, serving the same pharma sponsor buyers.

Emerging players

• Trial Library: Trial Library is a clinical trial matching and recruitment platform with a strong oncology and rare disease focus, often working with patient advocacy groups. Comparable to Power on the patient-recruitment side but more niche in therapeutic focus.

Broad incumbents

• ClinicalTrials.gov: The U.S. National Library of Medicine's free government-run registry of clinical trials. Not a competitor in the traditional sense, but the baseline reference for every patient and sponsor using Power's platform, and the structural cap on Power's pricing power.
• Medable: Medable provides decentralized clinical trial technology including eCOA, eConsent, telehealth, and patient recruitment tools sold to pharma sponsors. Comparable to Power as a clinical trial enablement vendor, though broader in scope and at significantly later stage.
• IQVIA: IQVIA is the largest CRO and clinical trial services company globally, with extensive patient recruitment capabilities. Overlaps with Power on pharma-sponsored patient recruitment but operates as a full-service incumbent with proprietary data assets.

Others

• Vivli: Vivli is a clinical trial data-sharing platform and registry. Not a direct recruiter like Power, but a thematically adjacent player in clinical trial infrastructure that sponsors may engage alongside or instead of recruitment platforms.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Power Life Science